Latest stories on CTY
City Therapeutics initiated with a Buy at Jefferies
The Fly63 · neutralanalyst
City Therapeutics initiated with a Buy at Stifel
The Fly64 · neutralanalyst
City Therapeutics Doses First Patient In City Rbp4 Trial
The Fly62 · neutralproduct/pr
CTY Initiates Coverage by Jefferies -- Price Target Announced at $32
GuruFocus58 · neutralanalyst
3 Stocks with More Than 40% Upside and Recent Buy Ratings from Analysts
TipRanks64 · neutralanalyst
City Therapeutics Doses First Participant in CITY-RBP4 Phase 1 Trial
TipRanks58 · neutralproduct/pr
CITY THERAPEUTICS, INC. (CTY) files 8-K
SEC 8-K50 · neutralgeneral
City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease
GlobeNewswire63 · neutralproduct/pr
Goldman Sachs initiates City Therapeutics stock at Early-Stage Biotech
Investing.com Analyst Ratings58 · neutralanalyst
CTY Initiates Coverage by Stifel -- Price Target Announced at $34.00
GuruFocus58 · neutralanalyst
Stifel initiates City Therapeutics stock with buy on pipeline
Investing.com Analyst Ratings64 · neutralanalyst
Jefferies initiates City Therapeutics stock with buy rating
Investing.com Analyst Ratings64 · neutralanalyst
City Therapeutics to Present at Upcoming November Investor Conferences
GlobeNewswire53 · neutralproduct/pr
City Therapeutics to Present at Upcoming November Investor Conferences
Business Insider52 · neutralproduct/pr
CITY THERAPEUTICS, INC. (CTY) files 8-K
SEC 8-K50 · neutralgeneral
City Therapeutics raises $230M in upsized Nasdaq IPO
Investing.com Markets64 · neutralgeneral
Opening Day: Biotech duo City Therapeutics, Iambic make debuts
The Fly58 · neutralgeneral
U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings
Seeking Alpha58 · neutralgeneral
RNAi drug developer City climbs after upsized IPO
Business Insider64 · neutralgeneral
City Therapeutics surges in market debut after upsizing $200M IPO
Investing.com Markets74 · bullishgeneral
City Therapeutics opened at $23, IPO priced at $18 per share
The Fly63 · neutralgeneral
City Therapeutics Shares Leap in Trading Debut After Upsized IPO
MarketWatch74 · bullishgeneral
RNAi Developer City Therapeutics Jumps 28% After Upsized US IPO
Bloomberg74 · bullishgeneral
City Therapeutics indicated to open at $22, IPO priced at $18
The Fly68 · bullishgeneral